Table 1. Characteristics of the included studies.
Author, Year | Sample size (EG▴) | Sample size (CG▴) | Age (EG) | Age (CG) | Disease severity (EG) | Disease severity (CG) | Intervention methods (/d) (EG) | Intervention methods (/d) (CG) | Duration treatment (/d) (EG/) | Duration treatment (/d) (CG) |
Yigong Zhang, 2000 [21] ▪ | 63 | 50 | 20∼76 | 24∼68 | The single joint disease: 54; uratoma:28; kidney damage: 1. | The single joint disease: 39; uratoma:10; kidney damage: 7. | Atractylodes lancea, Poria cocos, Polyporus Umbellatus, Pseudbubus Cremastra Seu pleiones et al. | Colchicine | 10 | 10 |
Liping Huang, 2003 [22] | 32 | 32 | 27∼63 | 27∼63 | The course of disease:1∼6 years. | The course of disease:1∼6 years. | Rhizoma Smilacis Glabrae (30 g), Coix Seed (30 g), Pseudbubus Cremastra Seu pleiones (30 g) et al. | Allopurinol (0.1 g*3) | 10 | 10 |
Pingyong Li, 2004 [23] | 60 | 64 | 37∼72 | 34∼72 | Primary gout; Kidney, liver damage: 0; coronary heart disease: 0; allergy: 0. | Primary gout; Kidney, liver damage: 0; coronary heart disease: 0; allergy: 0. | Pseudbubus Cremastra Seu pleiones (20 g), Rhizoma Smilacis Glabrae(20 g), Dioscorea tokoro (20 g) et al. | Colchicine (4∼8 mg), Allopurinol (0.3 g), Ibuprofen (0.1 g*3) | 10 | 10 |
Chongqing Yang, 2006 [24] ▪ | 30 | 30 | 18∼70 | 18∼70 | The course of disease:1∼5 years. | The course of disease:1∼5 years. | Rhizoma Smilacis Glabrae, Dioscorea tokoro Makino, Pseudbubus Cremastra Seu pleiones et al. | Diclofenac Sodium Enteric-coated Tablets (25 mg*3)♦ | 7 | 7 |
Lianqun Qiu, 2007 [25] | 34 | 16 | 38∼74 | 35–69 | The course of disease:0.5∼20 years | The course of disease:1∼16 years | Rhizoma Smilacis Glabrae (30 g), Semen Brassicae (20 g), Pseudbubus Cremastra Seu pleiones et al. | Allopurinol(0.1 g*2∼3), Meloxicam (7.5 mg) | 15 | 15 |
Huajie Wang, 2008 [26] ▪ | 42 | 41 | 22∼65 | 22∼65 | Primary gout: 42; kidney, liver damage: 0; coronary heart disease: 0; allergy: 0. | Primary gout: 41; kidney, liver damage: 0; coronary heart disease: 0; allergy: 0. | Rhizoma Smilacis Glabrae, Dioscorea tokoro Makino, Radix Achyranthis Bidentatae, et al. | Colchicine (0.5 mg), Benzbromarone (50 mg) | 21 | 21 |
Chenglong Tang, 2008 [27] | 30 | 26 | 28∼68 | 28∼68 | The course of disease: 1 month∼12 years. | The course of disease: 1 month∼12 years. | Atractylodes lancea (10 g), Cortex Phellodendri Chinensis (10 g), Pseudbubus Cremastra Seu pleiones (12 g) et al. | Colchicine (0.5 mg*2) Allopurinol (0.2 g*3) | 15 | 15 |
Ying Lu, 2008 [28] ▪ | 120 | 96 | 47∼78 | 47∼78 | The single joint disease: 216; uratoma:20; kidney damage: 76; coronary heart disease: 32.§ | No independent report based on this data has yet published. | Cortex Phellodendri Chinensis (15 g), Radix Stephaniae Tetrandrae (15 g), Coix Seed (15 g), Radix Angelicae Pubescentis (25 g), Geosaurus, Pseudbubus Cremastra Seu pleiones (25 g) et al. | Colchicine, Allopurinol | 30 | 30 |
Jin Yang, 2010 [29] | 30 | 30 | 40∼65 | 30∼64 | The course of disease: 2 ∼10years. | The course of disease: 2 ∼10years. | Cortex Phellodendri Chinensis (10 g), Atractylodes lancea (10 g), Pseudbubus Cremastra Seu pleiones (10 g), et al. | Difene (75 mg), Allopurinol (0.1 g*3) | 7 | 7 |
Bing Ji, 2010 [30] | 30 | 30 | 51.77±7.92 | 52.93±2.87 | The course of disease: 5.67±2.87 years. | The course of disease: 5.50±2.76 years. | Rhizoma Smilacis Glabrae (30 g), Rhizoma Polygoni Cuspidati (8 g), Coix Seed (30), Radix Cyathulae (15 g), et al. | Colchicine (0.5 mg*3), Celebrex (0.2 mg) | 7 | 7 |
Xiaoxia Wang, 2010 [31] | 30 | 30 | 48.5±15.5 | 49.1±13.7 | The course of disease: 1day∼12 years. | The course of disease: 2 day∼8 years. | Pseudbubus Cremastra Seu pleiones (12 g), Semen Persicae (12 g), Atractylodes lancea (12 g), Rhizoma Alismatis (20 g), et al. | Colchicine (0.5 g*2) | 10 | 10 |
Yu Ding, 2011 [32] | 40 | 36 | 28∼73 | 30∼80 | The course of disease: 12 h∼13 years. Recurrence: 12 | The course of disease: 10 h∼15 years. Recurrence: 14 | Atractylodes lancea (10 g), Cortex Phellodendri Chinensis (6 g), Coix Seed (20 g), Rhizoma Smilacis Glabrae (20 g) et al. | Allopurinol (0.1 g) Colchicine (0.5 g), Indomethacin (25 mg) | 7∼21 | 7∼21 |
Xizhou Zhang, 2011 [33] | 45 | 45 | 33∼60 | 35∼58 | The course of disease: 3 month ∼6 years. | The course of disease: 3 month ∼8 years. | Radix Scutellariae (6 g), Coptis chinensis Franch (6 g), Cortex Phellodendri Chinensis (12 g), Lilium brownii (12 g), et al. | Ibuprofen (0.3 g*2), Allopurinol (0.1 g*3) | 10 | 10 |
Mengyuan Liu, 2011 [34] | 30 | 30 | 35∼65 | 39∼65 | Kidney, liver damage: 0; coronary heart disease: 0; allergy: 0. | Kidney, liver damage: 0; coronary heart disease: 0; allergy: 0. | Atractylodes lancea (30 g), Cortex Phellodendri Chinensis (10 g), Coix Seed (30 g), Lilium brownii (10 g), et al. | Allopurinol (0.1 g*2) nimesulide (0.1 g) | 21 | 21 |
Yongkai Huang, 2011 [35] | 15 | 15 | 50.5±13.3 | 51.5±14.2 | Kidney, liver damage: 0; coronary heart disease: 0; allergy: 0. | Kidney, liver damage: 0; coronary heart disease: 0; allergy: 0. | Rhizoma Smilacis Glabrae (45 g), Dioscorea tokoro Makino (30 g), Coix Seed (30 g), Bombyx Batryticatus (15 g) et al. | Meloxicam Tablets (15 mg)• | 7 | 7 |
Yadong Han, 2011 [36] ▪ | 60 | 48 | 47∼78 | 47∼78 | The single joint disease: 108; kidney damage: 38; coronary heart disease: 18.§ | No independent report based on this data has yet published. | Cortex Phellodendri Chinensis (15 g), Radix Stephaniae Tetrandrae (15 g), Coix Seed (15 g), Lilium brownii (15 g), et al. | Colchicine, Allopurinol | 30 | 30 |
Baiyan Qin, 2011 [37] | 46 | 46 | 47.2±11.7 | 48.0±10.5 | The course of disease: 6 h∼23 years. Recurrence: 31 | The course of disease: 10 h∼19 years. Recurrence: 29 | Fructus Ligustri Lucidi (15 g), Rhizoma Anemarrhenae (10 g), Pseudbubus Cremastra Seu pleiones (15 g) et al. | Colchicine (0.5 mg*2), Allopurinol (0.1 g*3) | 10 | 10 |
EG Experimental group, CG Control group;
No dose be provided of intervention;
The molecular formula of main ingredients: C14H10Cl2NNa02;
The molecular formula of main ingredients: C14H13N3O4S2;
Including the data of experimental group and control group.